Daniel Bensen
Gründer bei TYRA BIOSCIENCES, INC.
Vermögen: 7 Mio $ am 30.04.2024
Ursprung des Netzwerks ersten Grades von Daniel Bensen
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Trius Therapeutics, Inc.
Trius Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Trius Therapeutics, Inc. is a biopharmaceutical company which focuses on the discovery, development and commercialization of innovative antibiotics for life-threatening infections. It engages in developing tedizolid phosphate an intravenous, or IV, and oral antibiotic, for the treatment of serious gram-positive bacterial infections, initially for acute bacterial skin and skin structure infections, ABSSSI, and subsequently for other indications, including pneumonia. ABSSSI is a new classification for complicated skin and skin structure infections, or cSSSI. Tedizolid phosphate is an IV and orally administered second generation oxazolidinone. The company develops antibiotics for gram-negative infections. Trius Therapeutics was founded by John Finn and John P. Schmid in June 2004, and is headquartered in San Diego, CA.
26
| Extinct | Pharmaceuticals: Major | 26 |
Public Company | Pharmaceuticals: Other | 24 | |
Public Company | Biotechnology | 23 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Daniel Bensen
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
ABBOTT LABORATORIES | Medical Specialties | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal Corporate Officer/Principal | |
CELGENE | Biotechnology | Director/Board Member Director/Board Member | |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal General Counsel Corporate Officer/Principal | |
MERCK & CO., INC. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal General Counsel Sales & Marketing Corporate Officer/Principal Corporate Officer/Principal | |
BIOGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Sales & Marketing | |
IONIS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | General Counsel Corporate Officer/Principal | |
CUBIST PHARMACEUTICALS INC | Pharmaceuticals: Major | Chief Executive Officer Chief Executive Officer Chief Administrative Officer Director of Finance/CFO Chief Tech/Sci/R&D Officer | |
Frazier Management LLC
Frazier Management LLC Investment ManagersFinance Frazier Management LLC (Frazier Healthcare Partners) is a venture capital subsidiary of Frazier & Co Inc. founded in 1991. The firm is headquartered in Seattle, Washington. | Investment Managers | Private Equity Investor Private Equity Investor | |
AVANIR PHARMACEUTICALS INC | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
ESPERION THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
NovaCardia, Inc.
NovaCardia, Inc. Pharmaceuticals: MajorHealth Technology NovaCardia, Inc. develops drugs to treat cardiovascular diseases. The company provides treatment for the patients by developing and commercializing clinical stage drug diseases. It also develops small molecule drugs. the company was founded in November, 2001 by Eckard Weber & Howard C. Dittrich and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member | |
VERACYTE, INC. | Medical Specialties | Director/Board Member Chairman Founder | |
MILESTONE PHARMACEUTICALS INC. | Pharmaceuticals: Major | Chairman Director/Board Member Director/Board Member | |
Labrys Biologics, Inc.
Labrys Biologics, Inc. BiotechnologyHealth Technology Labrys Biologics, Inc. provides biotechnology services. It is a venture-financed development stage biotechnology company, which focuses on treatments for chronic migraine. The company was founded by Corey S. Goodman in 2012 and is headquartered in San Francisco, CA. | Biotechnology | Director/Board Member Director/Board Member | |
Sofinnova Investments, Inc.
Sofinnova Investments, Inc. Investment ManagersFinance Sofinnova Investment Inc (Sofinnova Investment) is a venture capital firm founded in 1976 by Jacques F. vallle & Joel F. Martin. The firm is headquartered in Menlo Park, California. | Investment Managers | Private Equity Investor Private Equity Investor Corporate Officer/Principal | |
Stanford University | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
University of California, Los Angeles | College/University | Doctorate Degree Graduate Degree Doctorate Degree | |
OCERA THERAPEUTICS INC | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Massachusetts Institute of Technology | College/University | Doctorate Degree Doctorate Degree Undergraduate Degree | |
Indiana University | College/University | Masters Business Admin Undergraduate Degree Corporate Officer/Principal | |
Middlebury College | College/University | Undergraduate Degree Undergraduate Degree | |
University of California, Berkeley | College/University | Corporate Officer/Principal Undergraduate Degree Doctorate Degree | |
University of California, Davis | College/University | Graduate Degree Undergraduate Degree Undergraduate Degree | |
University of California San Diego | College/University | Doctorate Degree Undergraduate Degree Graduate Degree Undergraduate Degree | |
Optimer Pharmaceuticals LLC
Optimer Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Optimer Pharmaceuticals LLC operates as a biopharmaceutical company. It is focused on discovering, developing, and commercializing innovative hospital specialty products. Optimer Pharmaceuticals primarily concentrates on developing DIFICID and other fidaxomicin products. The company was founded by Michael N. Chang in 1998 and is headquartered in Jersey City, NJ. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
CADENCE PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Founder Human Resources Officer | |
BIOCOM
BIOCOM Miscellaneous Commercial ServicesCommercial Services BIOCOM provides scientific and technological services. The firm focuses that positively influence the growth of the life science industry, including capital formation, public policy, workforce development and scientific discovery and development. The company was founded in 1995 and is headquartered in San Diego, CA. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Pharmaceutical Research & Manufacturers of America
Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
Moximed, Inc.
Moximed, Inc. Medical SpecialtiesHealth Technology Moximed, Inc. develops minimally invasive, joint sparing solutions for patients with knee osteoarthritis. Its Osteoarthritis treatment can minimize joint pain, restore normal activity levels, and slow down disease progression. The company was founded by Anton G. Clifford in 2006 and is headquartered in Hayward, CA. | Medical Specialties | Director/Board Member Director/Board Member | |
UMass Chan Medical School | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
IGNYTA INC | Biotechnology | General Counsel Director/Board Member | |
Harvard Business School | College/University | Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin | |
QUINCE THERAPEUTICS, INC. | Biotechnology | Chief Executive Officer Director of Finance/CFO | |
PARATEK PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Dauntless Pharmaceuticals, Inc.
Dauntless Pharmaceuticals, Inc. Drugstore ChainsRetail Trade Dauntless Pharmaceuticals, Inc. develops specialty therapeutics via a one-asset, one-company model that is structured to facilitate operational efficiencies. The company was founded by Joel F. Martin and Michael F. Powell in May 2015 and is headquartered in San Diego, CA. | Drugstore Chains | Director/Board Member Founder Director/Board Member | |
VIR BIOTECHNOLOGY, INC. | Biotechnology | Director/Board Member Director/Board Member General Counsel | |
Forge Therapeutics, Inc.
Forge Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Forge Therapeutics, Inc. manufactures pharmaceutical products. It is a biotechnology company developing novel medicines by combining bio-inorganic with medicinal chemistry to target metalloproteins. The company was founded by Zachary A. Zimmerman, Seth Cohen and David Puerta and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO | |
Intrepida Bio, Inc.
Intrepida Bio, Inc. Pharmaceuticals: MajorHealth Technology Intrepida Bio, Inc. discovers and develops medicines to modulate the innate immune system to fight cancer and other diseases. The company was founded by Joel F. Martin and Olivier Laurent and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director/Board Member Chairman Director/Board Member | |
Novosteo, Inc.
Novosteo, Inc. Pharmaceuticals: MajorHealth Technology Novosteo, Inc. develops drug to reduce complications from a broken bone. The company was founded by Stewart A. Low and Philips S. Low in 2017 and is headquartered in West Lafayette, IN. | Pharmaceuticals: Major | Chief Executive Officer Chief Operating Officer | |
BOUNDLESS BIO, INC. | Biotechnology | Corporate Officer/Principal General Counsel |
Statistik
International
Vereinigte Staaten | 49 |
Kanada | 2 |
Sektoral
Health Technology | 34 |
Consumer Services | 10 |
Finance | 5 |
Commercial Services | 3 |
Retail Trade | 2 |
Operativ
Director/Board Member | 430 |
Corporate Officer/Principal | 159 |
Independent Dir/Board Member | 133 |
Director of Finance/CFO | 86 |
Chairman | 69 |
Am stärksten vernetzte Beziehungen
Insiders | |
---|---|
Daniel Geffken | 53 |
Nina Kjellson | 49 |
Michael Powell | 48 |
Robert More | 42 |
Patrick Heron | 42 |
Brian Atwood | 39 |
Steven Elms | 37 |
Michael Bonney | 32 |
Robert Perez | 31 |
David Kabakoff | 30 |
Karin Eastham | 29 |
Daniel Burgess | 28 |
Timothy Franson | 26 |
Risa Stack | 25 |
John Schmid | 24 |
- Börse
- Insiders
- Daniel Bensen
- Unternehmensverbindungen